These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8052076)

  • 1. Methotrexate therapy for autoimmune hearing loss: a preliminary report.
    Sismanis A; Thompson T; Willis HE
    Laryngoscope; 1994 Aug; 104(8 Pt 1):932-4. PubMed ID: 8052076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open trial of methotrexate as treatment for autoimmune hearing loss.
    Matteson EL; Fabry DA; Facer GW; Beatty CW; Driscoll CL; Strome SE; McDonald TJ
    Arthritis Rheum; 2001 Apr; 45(2):146-50. PubMed ID: 11324778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate management of immune-mediated cochleovestibular disorders.
    Sismanis A; Wise CM; Johnson GD
    Otolaryngol Head Neck Surg; 1997 Feb; 116(2):146-52. PubMed ID: 9051055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
    Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
    Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune inner ear disease: steroid and cytotoxic drug therapy.
    Lasak JM; Sataloff RT; Hawkshaw M; Carey TE; Lyons KM; Spiegel JR
    Ear Nose Throat J; 2001 Nov; 80(11):808-11, 815-6, 818 passim. PubMed ID: 11816893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; de Kleine E; van der Laan B; Albers F
    Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
    Street I; Jobanputra P; Proops DW
    J Laryngol Otol; 2006 Dec; 120(12):1064-6. PubMed ID: 17040588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
    Harris JP; Weisman MH; Derebery JM; Espeland MA; Gantz BJ; Gulya AJ; Hammerschlag PE; Hannley M; Hughes GB; Moscicki R; Nelson RA; Niparko JK; Rauch SD; Telian SA; Brookhouser PE
    JAMA; 2003 Oct; 290(14):1875-83. PubMed ID: 14532316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune disease of the inner ear].
    Cinco Balderas E; Paquot Chico RO; López Ríos G; Kim ML
    Gac Med Mex; 1992; 128(3):271-4. PubMed ID: 1302729
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss.
    McClelland L; Powell RJ; Birchall J
    Acta Otolaryngol; 2005 Dec; 125(12):1356-60. PubMed ID: 16303687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune inner ear disease in children.
    Huang NC; Sataloff RT
    Otol Neurotol; 2011 Feb; 32(2):213-6. PubMed ID: 21178803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent sudden sensorineural hearing loss sensitive to transtympanic and systemic steroid treatment: case report.
    Scapa VI; Friedland DR
    Ear Nose Throat J; 2009 Mar; 88(3):E14-9. PubMed ID: 19291620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric fluctuating sensorineural hearing loss: problems in medical management.
    Dinces EA; Yang S; Balogun AO
    Laryngoscope; 2001 Jan; 111(1):21-5. PubMed ID: 11192894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological investigation for sensorineural hearing loss in the otologic clinic: preliminary reports.
    Zanetti D; Franceschini F; Antonelli AR
    Acta Otorhinolaryngol Belg; 1994; 48(1):71-9. PubMed ID: 7513489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of methotrexate in Cogan's syndrome.
    Riente L; Taglione E; Berrettini S
    J Rheumatol; 1996 Oct; 23(10):1830-1. PubMed ID: 8895174
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute autoimmune sensorineural hearing loss associated with Crohn's disease.
    Bachmeyer C; Leclerc-Landgraf N; Laurette F; Coutarel P; Cadranel JF; Médioni J; Dhôte R; Mougeot-Martin M
    Am J Gastroenterol; 1998 Dec; 93(12):2565-7. PubMed ID: 9860428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate in the management of immune mediated cochleovesitibular disorders: clinical experience with 53 patients.
    Salley LH; Grimm M; Sismanis A; Spencer RF; Wise CM
    J Rheumatol; 2001 May; 28(5):1037-40. PubMed ID: 11361185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensorineural hearing loss after occlusion of the enlarged vestibular aqueduct.
    Welling DB; Slater PW; Martyn MD; Antonelli PJ; Gantz BJ; Luxford WM; Shelton C
    Am J Otol; 1999 May; 20(3):338-43. PubMed ID: 10337975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune inner ear disease preliminary case report: audiometric findings following steroid treatments.
    Harris DA; Mikulec AA; Carls SL
    Am J Audiol; 2013 Jun; 22(1):120-4. PubMed ID: 23800807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.